Tilray Brands, Inc. Net Income (Loss) Attributable to Noncontrolling Interest
Tilray Brands, Inc. (TLRY) reported Net Income (Loss) Attributable to Noncontrolling Interest of $16.24 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-07-28
- Tilray Brands, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-05-31 was $11.64M, a 137.61% increase year-over-year.
- Tilray Brands, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-02-28 was $1.34M.
- Tilray Brands, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-11-30 was $1.42M, a 2022.39% increase year-over-year.
- Tilray Brands, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-08-31 was $1.83M, a 59.34% decline year-over-year.
- Tilray Brands, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2026 was $16.24M, a 201.73% increase from fiscal 2025.
- Tilray Brands, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2025 was $5.38M, a 76.16% decline from fiscal 2024.
- Tilray Brands, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2024 was $22.58M, a 133.81% increase from fiscal 2023.
- Tilray Brands, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2023 was $9.66M, a 77.37% decline from fiscal 2022.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-05-31 | $11.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $12.98M derived: sum of 2 quarters · filed 2026-07-28 | $14.40M derived: sum of 3 quarters · filed 2026-07-28 | $16.24M 10-K · filed 2026-07-28 |
| 2026-02-28 | $1.34M 10-Q · filed 2026-04-01 | $2.76M derived: sum of 2 quarters · filed 2026-04-01 | $4.60M 10-Q · filed 2026-04-01 | $9.50M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-11-30 | $1.42M 10-Q · filed 2026-01-08 | $3.26M 10-Q · filed 2026-01-08 | $8.16M derived: sum of 3 quarters · filed 2026-07-28 | $4.06M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-08-31 | $1.83M 10-Q · filed 2025-10-09 | $6.74M derived: sum of 2 quarters · filed 2026-07-28 | $2.64M derived: sum of 3 quarters · filed 2026-07-28 | $2.70M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-05-31 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $802.00K derived: sum of 2 quarters · filed 2026-07-28 | $869.00K derived: sum of 3 quarters · filed 2026-07-28 | $5.38M 10-K · filed 2026-07-28 |
| 2025-02-28 | -$4.10M 10-Q · filed 2026-04-01 | -$4.03M derived: sum of 2 quarters · filed 2026-04-01 | $482.00K 10-Q · filed 2026-04-01 | $16.85M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-11-30 | $67.00K 10-Q · filed 2026-01-08 | $4.58M 10-Q · filed 2026-01-08 | $20.95M derived: sum of 3 quarters · filed 2026-07-28 | $8.67M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-08-31 | $4.51M 10-Q · filed 2025-10-09 | $20.89M derived: sum of 2 quarters · filed 2026-07-28 | $8.60M derived: sum of 3 quarters · filed 2026-07-28 | $11.43M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-05-31 | $16.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $4.09M derived: sum of 2 quarters · filed 2026-07-28 | $6.92M derived: sum of 3 quarters · filed 2026-07-28 | $22.58M 10-K · filed 2026-07-28 |
| 2024-02-29 | -$12.28M 10-Q · filed 2025-04-08 | -$9.46M derived: sum of 2 quarters · filed 2025-04-08 | $6.21M 10-Q · filed 2025-04-08 | $25.10M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-11-30 | $2.83M 10-Q · filed 2025-01-10 | $18.49M 10-Q · filed 2025-01-10 | $37.38M derived: sum of 3 quarters · filed 2025-07-29 | $12.63M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-08-31 | $15.66M 10-Q · filed 2024-10-10 | $34.56M derived: sum of 2 quarters · filed 2025-07-29 | $9.80M derived: sum of 3 quarters · filed 2025-07-29 | $17.63M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-05-31 | $18.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | -$5.86M derived: sum of 2 quarters · filed 2025-07-29 | $1.97M derived: sum of 3 quarters · filed 2025-07-29 | $9.66M 10-K · filed 2025-07-29 |
| 2023-02-28 | -$24.75M 10-Q · filed 2024-04-09 | -$16.93M derived: sum of 2 quarters · filed 2024-04-09 | -$9.24M 10-Q · filed 2024-04-09 | $11.10M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-11-30 | $7.83M 10-Q · filed 2024-01-09 | $15.52M 10-Q · filed 2024-01-09 | $35.86M derived: sum of 3 quarters · filed 2024-10-10 | $45.14M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-08-31 | $7.69M 10-Q · filed 2024-10-10 | $28.03M derived: sum of 2 quarters · filed 2024-10-10 | $37.31M derived: sum of 3 quarters · filed 2024-10-10 | $43.31M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-05-31 | $20.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $29.63M derived: sum of 2 quarters · filed 2024-07-30 | $35.62M derived: sum of 3 quarters · filed 2024-07-30 | $42.67M 10-K · filed 2024-07-30 |
| 2022-02-28 | $9.29M 10-Q · filed 2023-04-10 | $15.28M derived: sum of 2 quarters · filed 2023-04-10 | $22.33M 10-Q · filed 2023-04-10 | $15.61M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-11-30 | $6.00M 10-Q · filed 2023-01-09 | $13.04M 10-Q · filed 2023-01-09 | $6.32M derived: sum of 3 quarters · filed 2023-07-26 | $21.20M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-08-31 | $7.04M 10-Q · filed 2022-10-07 | $326.00K derived: sum of 2 quarters · filed 2023-07-26 | $15.20M derived: sum of 3 quarters · filed 2023-07-26 | $25.85M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-05-31 | -$6.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $8.16M derived: sum of 2 quarters · filed 2023-07-26 | $18.81M derived: sum of 3 quarters · filed 2023-07-26 | $31.41M 10-K · filed 2023-07-26 |
| 2021-02-28 | $14.88M 10-Q · filed 2022-04-06 | $25.53M derived: sum of 2 quarters · filed 2022-04-06 | $38.13M 10-Q · filed 2022-04-06 | |
| 2020-11-30 | $10.65M 10-Q · filed 2022-01-10 | $23.25M 10-Q · filed 2022-01-10 | ||
| 2020-08-31 | $12.60M 10-Q · filed 2021-10-07 | |||
| 2020-05-31 | $1.71M 10-K · filed 2022-07-28 | |||
| 2019-05-31 | -$11.06M 10-K · filed 2021-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |